| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.46 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |